InvestorsHub Logo
Followers 60
Posts 7400
Boards Moderated 0
Alias Born 10/20/2014

Re: dukesking post# 390245

Saturday, 10/08/2022 9:29:35 AM

Saturday, October 08, 2022 9:29:35 AM

Post# of 426490
Dukesking, AMRN management seemed unwilling and incapable of bringing
attention to the world of all of the great benefits of Vascepa...Especially in how
it could be used to treat the Cardiovascular inflammation that may result from
both Covid-19 as well as vaccines. The only way this will change is when a
BP such as Pfizer owns AMRN and Dr. Scott Gottlieb gets on TV and tells
the world that Vascepa is a safe and effective treatment for this inflammation.
Until that happens AMRN management will do nothing!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News